Tag: Pherecydes
Erytech Pharma merges with Pherecydes and becomes Phaxiam Therapeutics – 06/26/2023 at 10:11
(AOF) – Erytech Pharma is up 1.23% to 0.82 euro after announcing that all the resolutions for which the Board of Directors recommended a favorable vote were adopted by its…
Pherecydes Pharma/ Erytech Pharma: merger approved
(Boursier.com) — Pherecydes Pharma announces that the shareholders of Pherecydes Pharma (Pherecydes) andErytech Pharma (Erytech) have approved the merger between the two companies on the basis of a exchange parity…
Pherecydes Pharma: shareholders approve the merger – 06/23/2023 at 21:00
Pherecydes Pharma announces the results of its Combined General Meeting of June 23, 2023 Pherecydes Pharma and Erytech Pharma shareholders approve the merger between the two companies to create Phaxiam…
ERYTECH announces the approval of the merger with Pherecydes and announces the results of the Combined General Meeting of June 23, 2023 – 06/23/2023 at 10:30 p.m.
ERYTECH announces the approval of the merger with Pherecydes and communicates the results of the Combined General Meeting of June 23, 2023 All resolutions were passed by a large majority…
ERYTECH announces the approval of the merger with Pherecydes and announces the results of the Combined General Meeting of June 23, 2023 – 06/23/2023 at 10:30 p.m.
ERYTECH announces the approval of the merger with Pherecydes and communicates the results of the Combined General Meeting of June 23, 2023 All resolutions were passed by a large majority…
ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00
PRESS RELEASE ERYTECH announces that the Commercial Court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma Lyon (France), June 14, 2023 – 8:00 p.m.…
The Commercial Court rejects Akkadian’s request to postpone the vote on the merger: the shareholders of Pherecydes and Erytech will be able to vote on the merger on June 23, 2023 – 06/14/2023 at 20:00
Nantes, June 14, 2023 – 8 p.m. CEST – Pherecydes Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in precision phage therapy intended to treat resistant and/or complicated bacterial infections,…
ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00
Lyon (France), June 14, 2023 – ERYTECH Pharma (Euronext Paris and Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells, today announces that…
Pherecydes Pharma / Erytech: the TC of Lyon dismisses Akkadian
By Alexandra Saintpierre Published on 06/14/2023 at 9:38 p.m. Photo credit © Erytech (Boursier.com) — The biotechnology company…
Erytech: defends the Pherecydes project, accuses Akkadian – 06/12/2023 at 14:30
(CercleFinance.com) – Erytech on Monday accused the Akkadian investment fund of conducting a disinformation campaign against it by contesting its proposed merger with Pherecydes on the basis in particular of…
Pherecydes Pharma has submitted an application for authorization of a phase I clinical study in infective endocarditis caused by Staphylococcus aureus
By Hector Chaunu Published on 06/08/2023 at 07:35 Photo credit © ChaunuPictures (Boursier.com) — Pherecydes Pharmaa biotechnology company…
Pherecydes: application for clinical study authorization
(CercleFinance.com) – Pherecydes Pharma announced on Thursday that it had filed an application for authorization with the ANSM for a phase I clinical study in infective endocarditis caused by staphylococcus…